What is ASK120067;itraconazole used for?

ASK120067;itraconazole is indicated for Fungal infections.

Who makes ASK120067;itraconazole?

ASK120067;itraconazole is developed by Jiangsu Aosaikang Pharmaceutical Co., Ltd..

What development phase is ASK120067;itraconazole in?

ASK120067;itraconazole is in Phase 1.

What are the side effects of ASK120067;itraconazole?

Common side effects include Hepatotoxicity, QT interval prolongation.

Last reviewed 2026-04-23 · How we verify

ASK120067;itraconazole

Jiangsu Aosaikang Pharmaceutical Co., Ltd. · Phase 1 active Small molecule

Azole antifungal agent

Azole antifungal agent Used for Fungal infections.

At a glance

Generic name	ASK120067;itraconazole
Sponsor	Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Drug class	Azole antifungal
Target	Lanosterol 14α-demethylase
Modality	Small molecule
Therapeutic area	Infectious Disease
Phase	Phase 1

Mechanism of action

Inhibits lanosterol 14α-demethylase, a cytochrome P450 enzyme involved in the biosynthesis of ergosterol.

Approved indications

Fungal infections

Common side effects

Hepatotoxicity
QT interval prolongation

Key clinical trials

Drug-drug Interaction Study Beteewn ASK120067 and Rifampicin or Itraconazole (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ASK120067;itraconazole CI brief — competitive landscape report
ASK120067;itraconazole updates RSS · CI watch RSS
Jiangsu Aosaikang Pharmaceutical Co., Ltd. portfolio CI